FILING RECEIPT FOR TRADEMARK APPLICATION |
Dec 20, 2003 |
This acknowledges receipt on the FILING DATE of the application for registration for the mark identified below. The FILING DATE is contingent upon all minimum filing date requirements being met. Your application will be considered in the order in which it was received. Action on the merits should be expected from the United States Patent and Trademark Office (USPTO) approximately six months from the FILING DATE. When inquiring about this application, include the SERIAL NUMBER, FILING DATE, OWNER NAME and MARK. |
STEPHANIE K. WADE DICKSTEIN SHAPIRO MORIN & OSHINSKY LLP 2101 L STREET, N.W. WASHINGTON, D.C. 20037 |
ATTORNEY REFERENCE NUMBER C9994.0031 |
PLEASE REVIEW THE ACCURACY OF THE FILING RECEIPT DATA.
A request for correction to the filing receipt should be submitted within 30 days. Such request may be submitted by mail to: COMMISSIONER FOR TRADEMARKS , 2900 CRYSTAL DRIVE
, ARLINGTON , VIRGINIA 22202-3514 ; by fax to 703-308-9096; or by e-mail to tmfiling.receipt@uspto.gov. The USPTO will review the request and make corrections when appropriate. |
SERIAL NUMBER: | 76/560883 |
FILING DATE: | Nov 19, 2003 |
REGISTER: | Principal |
LAW OFFICE: | 105 |
MARK: | RANEXA |
MARK TYPE(S): | Trademark |
DRAWING TYPE: | Words, letters, or numbers and design |
FILING BASIS: | Sect. 1(b) (Intent to Use) |
ATTORNEY: | STEPHANIE K. WADE |
OWNER: | CV Therapeutics (DELAWARE, Corporation) 3172 Porter Drive Palo Alto , CALIFORNIA 94304 |
FOR: | pharmaceuticals for the treatment of cardiovascular diseases and conditions INT. CLASS: 005 |
FOR: | printed materials, namely pamphlets, brochures and newsletters about cardiovascular topics INT. CLASS: 016 |